UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
__________________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): August 14, 2007
Opexa Therapeutics, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Texas
(State or Other Jurisdiction of Incorporation)
001-33004 (Commission File Number) | 76-0333165 (I.R.S. Employer Identification No.) |
| | |
2635 N. Crescent Ridge Drive The Woodlands, Texas (Address of Principal Executive Offices) | 77381 (Zip Code) |
Registrant’s telephone number, including area code: (281) 272-9331
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| | |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| | |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| | |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 2.02. Results of Operations and Financial Condition.
On August 14, 2007 Registrant filed its Quarterly Report on Form 10-QSB for the quarter ended June 30, 2007. On August 14, 2007, Registrant announced its results of operations in a press release. A copy of the press release is attached as Exhibit 99.1.
(c) Exhibit 99.1
The following exhibit is to be filed as part of this 8-K:
Exhibit No. | Description |
| | |
| 99.1 | Press release issued August 14, 2007 |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | OPEXA THERAPEUTICS, INC. |
| | |
| | By: /s/David B. McWilliams |
| | David B. McWilliams |
| | President and Chief Executive Officer |
| | |
| | |
| DATE: October 3, 2007 | |
EXHIBIT INDEX
Exhibit No. | Description |
| | |
| 99.1 | Press release issued August 14, 2007 |
